Two-Drug attack on breast cancer before surgery shows promise
NCT ID NCT01723774
Summary
This study tested if adding a new drug called PD 0332991 to a standard hormone therapy (anastrozole) could better control early-stage breast cancer before surgery. It involved 84 women with a specific type of breast cancer that is hormone-sensitive. The main goal was to see if this combination could stop cancer cell growth more effectively than hormone therapy alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic - Rochester
Rochester, Minnesota, 55905, United States
-
Mayo Clinic - Scottsdale
Scottsdale, Arizona, 85259, United States
-
University of Alabama
Birmingham, Alabama, 35233, United States
-
Washington University School of Medicine
St Louis, Missouri, 63122, United States
Conditions
Explore the condition pages connected to this study.